Phosphorylation of serine 349 of p62 in Alzheimer's disease brain

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Tanji, Kunikazu ^a   Miki, Yasuo ^a   Ozaki, Taku ^a   Maruyama, Atsushi ^a   Yoshida, Hidemi ^b   Mimura, Junsei ^a   Matsumiya, Tomoh ^b   Mori, Fumiaki ^a   Imaizumi, Tadaatsu ^b   Itoh, Ken ^a   Kakita, Akiyoshi ^c   Takahashi, Hitoshi ^c   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Autophagy; Cytoplasmic inclusion; Keap1; Oxidative stress; P62 SQSTM1 sequestosome 1; Phosphorylation; Proteasome

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); CYSTEINE PROTEINASE INHIBITOR; PEPTIDE FRAGMENT; SERINE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; BRAIN; CELL CULTURE; CELL INCLUSION; CYTOLOGY; DRUG EFFECTS; FEMALE; HELA CELL LINE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; NEUROBLASTOMA; NEUROFIBRILLARY TANGLE; PATHOLOGY; PHOSPHORYLATION; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HELA CELLS; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; NEUROBLASTOMA; NEUROFIBRILLARY TANGLES; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SERINE;

EID: 84921681202     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-2-50     Document Type: Article

References (42)

1. Bedford L, Hay D, Devoy A, Paine S, Powe DG, Seth R, Gray T, Topham I, Fone K, Rezvani N, Mee M, Soane T, Layfield R, Sheppard PW, Ebendal T, Usoskin D, Lowe J, Mayer RJ: Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 2008, 28(33):8189-8198. 10.1523/JNEUROSCI.2218-08.2008
2. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K: Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441(7095):880-884. 10.1038/nature04723
3. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T: p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005, 171(4):603-614. 10.1083/jcb.200507002
4. Johansen T, Lamark T: Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7(3):279-296. 10.4161/auto.7.3.14487
5. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW: Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 2004, 24(18):8055-8068. 10.1128/MCB.24.18.8055-8068.2004
6. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T: p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282(33):24131-24145. 10.1074/jbc. M702824200
7. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T: LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004, 117(Pt 13):2805-2812.
8. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K: Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131(6):1149-1163. 10.1016/j.cell.2007.10.035
9. Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K: Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol 2012, 124(2):173-186. 10.1007/s00401-012-0975-7
10. Tanji K, Maruyama A, Odagiri S, Mori F, Itoh K, Kakita A, Takahashi H, Wakabayashi K: Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases. J Neuropathol Exp Neurol 2013, 72(1):18-28. 10.1097/NEN.0b013e31827b5713
11. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA: 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997, 68(5):2092-2097.
12. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G: Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994, 145(1):42-47.
13. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84. 10.1016/j.biocel.2006.07.001
14. Copple IM, Lister A, Obeng AD, Kitteringham NR, Jenkins RE, Layfield R, Foster BJ, Goldring CE, Park BK: Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway. J Biol Chem 2010, 285(22):16782-16788. 10.1074/jbc. M109.096545
15. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, Johansen T: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 2010, 285(29):22576-22591. 10.1074/jbc. M110.118976
16. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M: The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010, 12(3):213-223.
17. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T, Sun Z, White E, Zhang DD: A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 2010, 30(13):3275-3285. 10.1128/MCB.00248-10
18. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13(1):76-86. 10.1101/gad.13.1.76
19. Liu Y, Kern JT, Walker JR, Johnson JA, Schultz PG, Luesch H: A genomic screen for activators of the antioxidant response element. Proc Natl Acad Sci U S A 2007, 104(12):5205-5210. 10.1073/pnas.0700898104
20. Hancock R, Bertrand HC, Tsujita T, Naz S, El-Bakry A, Laoruchupong J, Hayes JD, Wells G: Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction. Free Radic Biol Med 2012, 52(2):444-451. 10.1016/j.freeradbiomed.2011.10.486
21. Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, Hoshii T, Hirao A, Takagi K, Mizushima T, Motohashi H, Lee MS, Yoshimori T, Tanaka K, Yamamoto M, Komatsu M: Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 2013, 51(5):618-631. 10.1016/j.molcel.2013.08.003
22. Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N: Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 2011, 44(2):279-289. 10.1016/j.molcel.2011.07.039
23. Tanji K, Zhang HX, Mori F, Kakita A, Takahashi H, Wakabayashi K: p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J Neurosci Res 2012, 90(10):2034-2042. 10.1002/jnr.23081
24. Tanji K, Kamitani T, Mori F, Kakita A, Takahashi H, Wakabayashi K: TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol Dis 2010, 38(2):210-218. 10.1016/j.nbd.2010.01.007
25. Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, Gartner C, Dimova N, Hanna J, Gygi SP, Wilson SM, King RW, Finley D: Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010, 467(7312):179-184. 10.1038/nature09299
26. Tanji K, Tanaka T, Mori F, Kito K, Takahashi H, Wakabayashi K, Kamitani T: NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol 2006, 169(2):553-565. 10.2353/ajpath.2006.051067
27. Pankiv S, Lamark T, Bruun JA, Overvatn A, Bjorkoy G, Johansen T: Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem 2010, 285(8):5941-5953. 10.1074/jbc. M109.039925
28. Olzmann JA, Li L, Chudaev MV, Chen J, Perez FA, Palmiter RD, Chin LS: Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 2007, 178(6):1025-1038. 10.1083/jcb.200611128
29. Busciglio J, Lorenzo A, Yeh J, Yankner BA: beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14(4):879-888. 10.1016/0896-6273(95)90232-5
30. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 1997, 94(24):13287-13292. 10.1073/pnas.94.24.13287
31. Ishii T, Yanagawa T, Kawane T, Yuki K, Seita J, Yoshida H, Bannai S: Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress. Biochem Biophys Res Commun 1996, 226(2):456-460. 10.1006/bbrc.1996.1377
32. Bartlett BJ, Isakson P, Lewerenz J, Sanchez H, Kotzebue RW, Cumming RC, Harris GL, Nezis IP, Schubert DR, Simonsen A, Finley KD: p62, Ref (2) P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 2011, 7(6):572-583. 10.4161/auto.7.6.14943
33. Keller JN, Hanni KB, Markesbery WR: Impaired proteasome function in Alzheimer's disease. J Neurochem 2000, 75(1):436-439.
34. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R: Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A 2000, 97(18):9902-9906. 10.1073/pnas.170173897
35. Lopez Salon M, Morelli L, Castano EM, Soto EF, Pasquini JM: Defective ubiquitination of cerebral proteins in Alzheimer's disease. J Neurosci Res 2000, 62(2):302-310. 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L
36. Hu X, Crick SL, Bu G, Frieden C, Pappu RV, Lee JM: Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A 2009, 106(48):20324-20329. 10.1073/pnas.0911281106
37. Nixon RA, Cataldo AM, Mathews PM: The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem Res 2000, 25(9-10):1161-1172.
38. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG: Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 1998, 52(6):691-698. 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3
39. Arai T, Nonaka T, Hasegawa M, Akiyama H, Yoshida M, Hashizume Y, Tsuchiya K, Oda T, Ikeda K: Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett 2003, 342(1-2):41-44.
40. Kuusisto E, Salminen A, AlafuzoffI: Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 2001, 12(10):2085-2090. 10.1097/00001756-200107200-00009
41. Nakano T, Nakaso K, Nakashima K, Ohama E: Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum. Acta Neuropathol 2004, 107(4):359-364. 10.1007/s00401-004-0821-7
42. Babu JR, Geetha T, Wooten MW: Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 2005, 94(1):192-203. 10.1111/j.1471-4159.2005.03181.x